1998
DOI: 10.1590/s1020-49891998000500015
|View full text |Cite
|
Sign up to set email alerts
|

The economics of pharmaceuticals and health sector reform in the Americas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

2001
2001
2020
2020

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 0 publications
0
5
0
1
Order By: Relevance
“…In countries with left-aligned governments, values such as interculturality, public financing, prevention, and right to health prevail (e.g., Bolivia, Cuba, Ecuador, Venezuela) [ 26 , 79 , 81 – 84 ] External factors • Situational values influence the policy selection when aligned with international recommendations or requirements ◦ Latin America countries have been influenced by international agencies like the World Bank, the International Monetary Fund, WHO, PAHO, and UN. The influence of international agencies has been through a process of policy transfer, sometimes more persuasive and sometimes more coercive, which has resulted in many Latin American countries sharing a number of common characteristics [ 20 , 25 , 28 , 29 , 35 , 45 , 47 , 57 , 59 , 81 , 85 87 ] • Situational values are used to prioritize policies to be implemented when aligned with specific situational influences ◦ Perhaps the value that has had the greatest presence in the implementation of health reforms in Latin America has been decentralization, which was one of the key elements of the World Bank recommendations in the 80s and 90s [ 32 , 47 , 57 , 88 ] …”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…In countries with left-aligned governments, values such as interculturality, public financing, prevention, and right to health prevail (e.g., Bolivia, Cuba, Ecuador, Venezuela) [ 26 , 79 , 81 – 84 ] External factors • Situational values influence the policy selection when aligned with international recommendations or requirements ◦ Latin America countries have been influenced by international agencies like the World Bank, the International Monetary Fund, WHO, PAHO, and UN. The influence of international agencies has been through a process of policy transfer, sometimes more persuasive and sometimes more coercive, which has resulted in many Latin American countries sharing a number of common characteristics [ 20 , 25 , 28 , 29 , 35 , 45 , 47 , 57 , 59 , 81 , 85 87 ] • Situational values are used to prioritize policies to be implemented when aligned with specific situational influences ◦ Perhaps the value that has had the greatest presence in the implementation of health reforms in Latin America has been decentralization, which was one of the key elements of the World Bank recommendations in the 80s and 90s [ 32 , 47 , 57 , 88 ] …”
Section: Resultsmentioning
confidence: 99%
“…◦ Latin America countries have been influenced by international agencies like the World Bank, the International Monetary Fund, WHO, PAHO, and UN. The influence of international agencies has been through a process of policy transfer, sometimes more persuasive and sometimes more coercive, which has resulted in many Latin American countries sharing a number of common characteristics [ 20 , 25 , 28 , 29 , 35 , 45 , 47 , 57 , 59 , 81 , 85 87 ]…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…As a result, those who most need basic health services are increasingly unable to meet their needs. Ministries of health must focus the momentum for change on developing mechanisms to meet such needs, and they must do so by involving both the public and private sectors [18].…”
Section: Health and Pharmaceutical Expendituresmentioning
confidence: 99%
“…Según Patricia Danzón y Adrian Towse (Danzon & Towse, 2005) las farmacéuticas tienen bastante cautela al fijar un precio bajo en otros países debido a que los reguladores de países de la OCDE con mecanismos de control de precios pueden tomar dicho precio como "precio de referencia" 31 (Madrid, 1998). Por ejemplo, si las farmacéuticas comercializan un antirretroviral al precio de un centavo la píldora dentro de territorio africano, el regulador de Canadá, podría resistirse a permitir que se comercialice a cien o doscientos dólares la misma píldora en territorio canadiense, incluso si la Junta de Revisión de Precios de Medicamentos -el regulador de precios de Canadá-entiende que las empresas deben recuperar la inversión de millones de dólares en I + D.…”
Section: Discriminación De Preciosunclassified